SUZHOU, China, Nov. 21, 2025 /PRNewswire/ -- On November 20, 2025, BioDlink (Stock Code: 1875.HK), a leading biologics CDMO, together with Lepu Biopharma (2157.HK), announced the successful market ...

From payload optimization to integrated GMP manufacturing, companies aim to elevate oncology ADCs to standard of care.

From a chemistry, manufacturing, and controls (CMC) perspective, ADCs present unique hurdles. “ADCs introduce unique challenges across areas like process and purification development, analytical ...

SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- WuXi XDC ("XDC"), a leading global CRDMO company dedicated to end-to-end bioconjugates services, announced that it received the Runner Up prize in the "Best ...

With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and ...

The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antibody drug conjugate (ADC) development. As part of the broader ...

FRANKFURT, Germany, Oct. 29, 2025 /PRNewswire/ -- Thousand Oaks Biologics, a leading Asia-based CRDMO specializing in macromolecules, today announced its participation in CPHI Frankfurt 2025, held ...